Abstract
The authors assessed the consequences of stopping antipsychotic medication in nursing home patients with dementia, as mandated by federal regulations (OBRA 87). They studied three patient groups: 1) a group ("clinical judgment") whose antipsychotics were discontinued at the discretion of their physicians; 2) a group ("empirical") with mandated cessation of antipsychotics in the facility; and 3) a comparison group of patients not receiving medication. The primary outcome measure was the necessity to resume antipsychotic or other psychotropic medication ("failure"). Also, assessments of behavior, function, neurologic status, and cognition were performed by blind raters. The failure rate in the empirical withdrawal group was 50%, 10 times that of the clinical judgment group. Among failures, the most striking result was increased verbal and physical aggression. No failures occurred in the comparison group. There were no benefits of antipsychotic withdrawal in terms of neurological performance, functional status, or cognition.
Citations
Jul 1, 1997·Journal of Geriatric Psychiatry and Neurology·S Bridges-ParletS Steffes
Oct 31, 2002·Human Psychopharmacology·M. Tsolaki
Apr 2, 2018·The Cochrane Database of Systematic Reviews·Ellen Van LeeuwenThierry Christiaens
Apr 2, 2013·The Cochrane Database of Systematic Reviews·Tom DeclercqThierry Christiaens
Nov 22, 2008·Drugs & Aging·Shoba IyerDavid G Le Couteur
Mar 10, 2001·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·N Herrmann
Aug 17, 2011·International Journal of Geriatric Psychiatry·D P DevanandKaren Marder
Oct 19, 2012·The New England Journal of Medicine·D P DevanandBruce Levin
Jun 10, 2000·Journal of Advanced Nursing·M M Knight
Sep 11, 2020·International Journal of Clinical Pharmacy·Raymond LinBin GaoAtul Sunny Luthra
Oct 17, 1998·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·A J Flint, R van Reekum
Mar 29, 2003·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·George T Grossberg, Abhilash K Desai
Apr 15, 2016·British Journal of Clinical Pharmacology·Amy T PageChristopher D Etherton-Beer